COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.

Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients / Magnocavallo, M.; Vetta, G.; Della Rocca, D. G.; Gianni, C.; Mohanty, S.; Bassiouny, M.; Di Lullo, L.; Del Prete, A.; Cirone, D.; Lavalle, C.; Chimenti, C.; Al-Ahmad, A.; Burkhardt, J. D.; Gallinghouse, G. J.; Sanchez, J. E.; Horton, R. P.; Di Biase, L.; Natale, A.. - In: CARDIAC ELECTROPHYSIOLOGY CLINICS. - ISSN 1877-9182. - 14:1(2022), pp. 1-9. [10.1016/j.ccep.2021.10.001]

Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients

Magnocavallo M.
Primo
;
Lavalle C.;Chimenti C.;
2022

Abstract

COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.
2022
COVID-19; supraventricular arrhythmias; atrial fibrillation; catheter ablation; atrial flutter; rhythm control
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients / Magnocavallo, M.; Vetta, G.; Della Rocca, D. G.; Gianni, C.; Mohanty, S.; Bassiouny, M.; Di Lullo, L.; Del Prete, A.; Cirone, D.; Lavalle, C.; Chimenti, C.; Al-Ahmad, A.; Burkhardt, J. D.; Gallinghouse, G. J.; Sanchez, J. E.; Horton, R. P.; Di Biase, L.; Natale, A.. - In: CARDIAC ELECTROPHYSIOLOGY CLINICS. - ISSN 1877-9182. - 14:1(2022), pp. 1-9. [10.1016/j.ccep.2021.10.001]
File allegati a questo prodotto
File Dimensione Formato  
Magnocavallo_Prevalence_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 796.41 kB
Formato Adobe PDF
796.41 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1634468
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 7
  • ???jsp.display-item.citation.isi??? ND
social impact